MEI Pharma Inc. has become the first U.S.-listed public company to adopt litecoin ( LTC) as a primary reserve asset, deploying $100 million from a recent stock sale to acquire 929,548 tokens of the cryptocurrency. Litecoin Creator Charlie Lee Joins MEI Pharma’s Board The clinical-stage biopharmaceutical company (Nasdaq: MEIP) disclosed the LTC acquisition in an […]Bitcoin NewsRead More
Related Posts
Iran Launches Digital Rial Pilot on Kish Island
The Central Bank of Iran (CBI) has announced the initiation of a pilot scheme to introduce the country’s central bank digital currency (CBDC) on the […]
Xi Jinping Backs BRICS Bank’s Growth as Key Driver for Global South Economies
Chinese President Xi Jinping underscored BRICS’ New Development Bank (NDB) as a crucial emerging force in the global financial system during discussions with NDB President […]
Chaos Labs Secures $55M Series A Funding to Bolster Defi Risk Management Solutions
Chaos Labs has raised $55 million in a Series A funding round, led by Haun Ventures, to advance its onchain risk management platform for decentralized […]
